Project Grant MM983449013

This $2,054,187.00 Centers for Disease Control and Prevention (CDC) Cooperative Agreement, awarded on September 1, 2024 under the Investigations and Technical Assistance program (CFDA 93.283), aims to advance health equity in asthma control through the EXHALE strategies. The prime awardee, Health Research, Inc., will deliver a range of public health services and interventions focused on improving asthma outcomes, particularly among high-risk populations. Key activities include research,...

The Minnesota Department of Health (MDH) was awarded a $2,268,912 cooperative agreement from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The purpose of this 4-year award, effective September 1, 2024, is to increase guidelines-based asthma care, patient self-management, and access to social determinants of health in order to improve asthma control and reduce disparities. MDH will implement the EXHALE...

The Centers for Disease Control and Prevention (CDC) awarded a $1,349,184 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the Delaware Division of Public Health. The funding will support a multi-year effort to advance health equity in asthma control through the implementation of EXHALE strategies. Key activities include: Coordinating care and linkages between healthcare providers, community organizations, and schools to support asthma...

This federal Cooperative Agreement award of $3,188,645.00 from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) will support the "Advancing Health Equity in Pennsylvania's Asthma Control Through EXHALE Strategies" project. The Pennsylvania Department of Health (PADOH) is the prime awardee and will collaborate with sub-awardees including Public Health Management Corporation, The Children's Hospital of Philadelphia,...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,349,184 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the District of Columbia Department of Health (DC Health) to implement the "DC EXHALE ASTHMA: IMPLEMENTING EXHALE STRATEGIES TO ADVANCE HEALTH EQUITY IN DC" project. The 4-year grant, commencing on September 1, 2024, will support DC Health in delivering comprehensive asthma prevention and management...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $2,054,187 Cooperative Agreement to the California Department of Public Health (CDPH) under the CDC Investigations and Technical Assistance program (CFDA 93.283). This 4-year award, running from September 1, 2024 to August 31, 2028, will support CDPH's efforts to expand the reach, quality, and effectiveness of asthma control services in high-burden areas of California. The CDC Investigations and Technical Assistance program...

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the CFDA Program 93.283 "CDC Investigations and Technical Assistance," aims to advance health equity in asthma control through EXHALE strategies. The $1,560,687 award, with a performance period from Sep 1, 2024 to Aug 31, 2028, will be administered by the Health Services Kentucky Cabinet For, a U.S. state government entity. The project focuses on research, surveillance,...

This Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283), is focused on "Advancing Health Equity in Asthma Control through EXHALE Strategies." The $2,268,912 award, spanning from September 1, 2024 to August 31, 2028, supports a comprehensive initiative to improve asthma control and address related health disparities. The prime awardee, the State of Wisconsin Department of...

The Michigan Department of Health and Human Services (MDHHS) was awarded a $2,456,916 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to operate the Michigan Asthma Prevention and Control Program. The 4-year grant, effective September 1, 2024, will fund activities to control communicable diseases, chronic diseases, and other preventable health conditions in Michigan. Under this award, MDHHS will...

The federal Cooperative Agreement award NUE1EH001526 titled "ADVANCING HEALTH EQUITY IN ASTHMA CONTROL THROUGH EXHALE STRATEGIES" was awarded by the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The $1,349,187 award, effective September 1, 2024 through August 31, 2028, will support the Vermont Agency of Human Services in implementing public health strategies to improve asthma control and promote health...